UCPH spin-out to develop the future's obesity medicine with Novo Nordisk

Less than a year after Embark Biotech was spun out from University of Copenhagen, the new Danish biotech company has entered a comprehensive collaboration with Novo Nordisk.
Embark Biotech is based in Cobis Science Park | Photo: Jan Bjarke Mindegaard
Embark Biotech is based in Cobis Science Park | Photo: Jan Bjarke Mindegaard

Last year, Danish drug group Novo Nordisk set a strategy that involved bringing in more external innovation to the company. This year, the firm has already been in Germany, England and especially the US to find new partners.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading